Tezspire - Tezepelumab-ekko 210 mg / 1.9mL Injection 1.91 mL

Reference details for licensed healthcare facility review and verification.

NDC 1155513-0112-99
Product NDC55513-0112
Generic Drug Nametezepelumab-ekko
Brand NameTezspire
ManufacturerAmgen Inc
Strength210 mg / 1.9mL
Dosage FormInjection
Drug TypeSubcutaneous
Package Quantity1.91 mL
Package Description1.91 mL in 1 SYRINGE (55513-112-99)
Active IngredientsTezepelumab
Marketing CategoryBLA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

tezepelumab-ekko 210 mg / 1.9mL Injection is tracked under NDC 55513-0112-99 and rolls up into product family 55513-0112. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 1.91 mL.
  • Manufacturer: Amgen Inc.
  • Dosage form: Injection.
  • Family size: 3 indexed presentations.

Click a tag to refine the catalog view around this product reference.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Alternate presentations in this family

These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Tezspire - Tezepelumab-ekko 210 mg / 1.9mL Injection 1.91 mL, NDC 55513-0112-99, is a Amgen Inc 210 mg / 1.9mL injection presentation packaged as 1.91 mL.

NDC search formats

  • Canonical NDC 11: 55513-0112-99
  • Digits-only NDC 11: 55513011299
  • Possible 10-digit display format: 55513-112-99 (5551311299)

Helpful product links